Humana took a hit last week after the Centers for Medicare and Medicaid Services cut the quality rating of the company’s ...
After six straight sessions of losses that followed the company’s recent update on its Medicare Advantage business, Humana ...
The stock market was up in the third quarter, but many stocks still took it on the chin, including Occidental Petroleum and ...
Today, Benzinga 's options scanner spotted 15 uncommon options trades for Humana. This isn't normal. The overall sentiment of ...
TD Cowen analyst Ryan Langston downgraded the rating on Humana (HUM – Research Report) to a Hold today, setting a price target of ...
The insurer’s stock sank to its lowest level in more than a decade after the federal government lowered the rating for one of ...
Humana (HUM) stock faces a 15% premarket dip as it discloses a significant decline in mmbers enrolled in highly rated ...
Analyst Steve Baxter of Wells Fargo maintained a Buy rating on Humana (HUM – Research Report), retaining the price target of $387.00. Steve Baxter has given his Buy rating due to a combination of ...
About a quarter of members in plans that Humana manages for the US Medicare program for the elderly were in four-star rated ...
Shares of Humana have tumbled after the health insurer said a Medicare Advantage quality rating drop will hurt future bonus ...
Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer disclosed Wednesday. The downgrade could wipe out Humana’s profits in 2026.
Medicare Advantage quality ratings for the company dropped, meaning a big drop in revenue from bonus payments.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback